353 related articles for article (PubMed ID: 9884244)
1. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
[TBL] [Abstract][Full Text] [Related]
2. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
3. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
[TBL] [Abstract][Full Text] [Related]
5. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
8. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
[TBL] [Abstract][Full Text] [Related]
9. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
10. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
11. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
12. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice.
Qian S; Li W; Li Y; Fu F; Lu L; Fung JJ; Thomson AW
Transplantation; 1996 Dec; 62(12):1709-14. PubMed ID: 8990348
[TBL] [Abstract][Full Text] [Related]
15. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
[TBL] [Abstract][Full Text] [Related]
16. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
Chen X; Zhao S; Tang X; Ge H; Liu P
Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
[TBL] [Abstract][Full Text] [Related]
18. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
[TBL] [Abstract][Full Text] [Related]
19. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
20. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
